Published in AIDS Res Hum Retroviruses on March 01, 2004
Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell (2010) 3.42
SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology (2012) 2.92
Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J Virol (2005) 2.55
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J Virol (2005) 2.23
A novel monoclonal antibody against human Argonaute proteins reveals unexpected characteristics of miRNAs in human blood cells. RNA (2007) 2.13
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA. J Virol (2005) 1.80
Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection. J Virol (2004) 1.68
HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. Virology (2007) 1.61
Viral complementation allows HIV-1 replication without integration. Retrovirology (2008) 1.52
A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients. Virology (2008) 1.45
Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. J Virol (2007) 1.45
Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells. PLoS Pathog (2009) 1.45
A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients. J Virol (2005) 1.32
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. J Virol (2007) 1.31
Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells. J Virol (2009) 1.09
HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy. J Virol (2014) 1.09
HIV latency: present knowledge, future directions. Future Virol (2006) 1.04
High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections. Proc Natl Acad Sci U S A (2009) 1.04
Centrosomal latency of incoming foamy viruses in resting cells. PLoS Pathog (2007) 1.02
Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy. Mol Ther (2010) 0.98
Centrosomal pre-integration latency of HIV-1 in quiescent cells. Retrovirology (2007) 0.97
Cocaine exposure enhances permissiveness of quiescent T cells to HIV infection. J Leukoc Biol (2013) 0.93
MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. Viruses (2012) 0.90
Differentially stimulated CD4+ T cells display altered human immunodeficiency virus infection kinetics: implications for the efficacy of antiviral agents. J Virol (2009) 0.90
HIV restriction in quiescent CD4⁺ T cells. Retrovirology (2013) 0.88
Quiescent T cells and HIV: an unresolved relationship. Immunol Res (2010) 0.87
Efficient delivery of lentiviral vectors into resting human CD4 T cells. Gene Ther (2014) 0.80
Dissecting How CD4 T Cells Are Lost During HIV Infection. Cell Host Microbe (2016) 0.80
HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines. J Virol (2015) 0.77
Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA. Virol J (2012) 0.76
Distribution and fate of HIV-1 unintegrated DNA species: a comprehensive update. AIDS Res Ther (2017) 0.75
On the death rate of abortively infected cells: estimation from simian/human immunodeficiency virus infection. J Virol (2017) 0.75
Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration. PLoS Pathog (2017) 0.75
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature (2002) 21.53
DNA deamination mediates innate immunity to retroviral infection. Cell (2003) 12.10
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med (2003) 9.22
Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol (2004) 6.51
Towards an HIV cure: a global scientific strategy. Nat Rev Immunol (2012) 5.52
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol (2005) 4.98
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis (2012) 4.24
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog (2013) 4.05
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol (2006) 3.27
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J Biol Chem (2006) 3.03
Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol (2009) 2.95
APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci (2007) 2.80
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature (2013) 2.79
APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog (2008) 2.60
A sensitive, quantitative assay for human immunodeficiency virus type 1 integration. J Virol (2002) 2.54
Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol (2006) 2.50
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J Virol (2005) 2.23
Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation. J Virol (2007) 2.17
APOBEC-mediated editing of viral RNA. Science (2004) 2.15
A novel monoclonal antibody against human Argonaute proteins reveals unexpected characteristics of miRNAs in human blood cells. RNA (2007) 2.13
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog (2013) 2.06
Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J Virol (2002) 1.91
Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. Methods (2009) 1.91
Guidelines for naming nonprimate APOBEC3 genes and proteins. J Virol (2008) 1.86
RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog (2009) 1.84
APOBEC-mediated interference with hepadnavirus production. Hepatology (2005) 1.82
Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART. PLoS Pathog (2011) 1.77
Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J (2004) 1.77
Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J Virol (2010) 1.69
HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. Virology (2007) 1.61
DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat Immunol (2003) 1.54
Hypermutation of an ancient human retrovirus by APOBEC3G. J Virol (2008) 1.50
TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Mol Biol Cell (2007) 1.47
HIV integration site distributions in resting and activated CD4+ T cells infected in culture. AIDS (2009) 1.46
Further investigation of simian immunodeficiency virus Vif function in human cells. J Virol (2004) 1.46
A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients. Virology (2008) 1.45
Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells. J Virol (2009) 1.45
HIV latency and integration site placement in five cell-based models. Retrovirology (2013) 1.42
Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions. J Virol (2003) 1.41
Comment on "Inhibition of hepatitis B virus replication by APOBEC3G". Science (2004) 1.41
Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J Virol (2008) 1.37
Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins. Virology (2005) 1.36
Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency. PLoS Pathog (2012) 1.34
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. J Virol (2007) 1.31
Retrovirus RNA trafficking: from chromatin to invasive genomes. Traffic (2006) 1.30
HIV reservoirs and latency models. Virology (2011) 1.29
Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials. AIDS (2012) 1.27
The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope. J Virol (2009) 1.20
Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection. Retrovirology (2013) 1.16
The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex. PLoS Pathog (2010) 1.15
Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure. J Virol (2010) 1.15
Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages. J Virol (2011) 1.12
Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood (2012) 1.12
Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells. J Virol (2009) 1.07
SnapShot: HIV-1 proteins. Cell (2008) 1.06
Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology (2007) 1.05
Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected]. PLoS One (2013) 1.01
Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses. Retrovirology (2012) 1.00
HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells. Virology (2013) 0.99
SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. J Virol (2010) 0.98
Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs. Virology (2011) 0.98
The evolving role of plerixafor in hematopoietic progenitor cell mobilization. Transfusion (2013) 0.95
HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. J Virol (2012) 0.94
Nuclear import of SAMHD1 is mediated by a classical karyopherin α/β1 dependent pathway and confers sensitivity to VpxMAC induced ubiquitination and proteasomal degradation. Retrovirology (2014) 0.90
AIDS/HIV. HIV interplay with SAMHD1. Science (2012) 0.89
Quantitation of integrated proviral DNA in viral reservoirs. Curr Opin HIV AIDS (2013) 0.87
Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations. PLoS One (2010) 0.87
Evolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replication. PLoS Pathog (2011) 0.86
The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses. J Gen Virol (2011) 0.85
R5 HIV env and vesicular stomatitis virus G protein cooperate to mediate fusion to naive CD4+ T Cells. J Virol (2010) 0.81
Quantitation of HIV DNA integration: effects of differential integration site distributions on Alu-PCR assays. J Virol Methods (2013) 0.81
The Next Generation of Targeted Molecules for the Treatment of Chronic Lymphocytic Leukemia. Oncology (Williston Park) (2016) 0.79
Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs. J Clin Apher (2010) 0.78
Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction. Open Biol (2013) 0.77
Can digitally reconstructed radiographs (DRRS) replace simulation films in prostate cancer conformal radiotherapy? Int J Radiat Oncol Biol Phys (2003) 0.77
Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen. J Infect Dis (2013) 0.76
Hematopoietic stem cells and HIV infection. J Infect Dis (2013) 0.76
Corrigendum: Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat Immunol (2016) 0.75
American Society for Apheresis white paper: considerations for medical staff apheresis medicine physician credentialing and privileging. J Clin Apher (2012) 0.75
An ab initio molecular orbital study of the reduction of carbonyls by alkylaluminum complexes. J Mol Graph Model (2005) 0.75
Corrigendum: Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat Immunol (2016) 0.75
A plea for justice for jailed medical workers. Science (2006) 0.75